NASDAQ:PPDI - Pharmaceutical Product Development Stock Price, Price Target & More

Previous CloseN/A

Today's RangeN/A

52-Week RangeN/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

About Pharmaceutical Product Development (NASDAQ:PPDI)

Pharmaceutical Product Development, Inc. is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Its development services include preclinical programs and Phase I through Phase IV clinical development services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services. The Company operates in two segments: Development and Discovery Sciences. In May 2009, the Company completed its disposition of its wholly owned subsidiary Piedmont Research Center, LLC. In December 2009, the Company completed its disposition of its wholly owned subsidiary PPD Biomarker Discovery Sciences, LLC. On April 2, 2009, the Company acquired Magen BioSciences, Inc. On April 21, 2009, the Company acquired AbC.R.O., Inc. On November 6, 2009, the Company acquired Excel PharmaStudies, Inc.

Receive PPDI News and Ratings via Email

Sign-up to receive the latest news and ratings for PPDI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryN/A

SectorN/A

SymbolNASDAQ:PPDI

CUSIPN/A

Webwww.ppdi.com

Phone+1-910-2510081

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Pharmaceutical Product Development (NASDAQ:PPDI) Frequently Asked Questions

What is Pharmaceutical Product Development's stock symbol?

Pharmaceutical Product Development trades on the NASDAQ under the ticker symbol "PPDI."

Has Pharmaceutical Product Development been receiving favorable news coverage?

News coverage about PPDI stock has trended somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Pharmaceutical Product Development earned a news impact score of 0.13 on Accern's scale. They also gave media coverage about the healthcare company an impact score of 49.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Pharmaceutical Product Development?

Shares of PPDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Pharmaceutical Product Development?

Pharmaceutical Product Development's mailing address is 929 N Front St, WILMINGTON, NC 28401-3331, United States. The healthcare company can be reached via phone at +1-910-2510081.

MarketBeat Community Rating for Pharmaceutical Product Development (PPDI)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		67 (Vote Outperform)
Underperform Votes:		67 (Vote Underperform)
Total Votes:		134

MarketBeat's community ratings are surveys of what our community members think about Pharmaceutical Product Development and other stocks. Vote "Outperform" if you believe PPDI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PPDI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Pharmaceutical Product Development (NASDAQ:PPDI) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details

(Data available from 4/24/2016 forward)

Pharmaceutical Product Development (NASDAQ:PPDI) Earnings History and Estimates Chart

Earnings by Quarter for Pharmaceutical Product Development (NASDAQ:PPDI)

Pharmaceutical Product Development (NASDAQ PPDI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/2/2011	Q3 2011	$0.42	$0.31	View	N/A
7/26/2011	Q2 2011	$0.38	$0.41	View	N/A
4/26/2011		$0.33	$0.32	View	N/A
2/8/2011		$0.38	$0.40	View	N/A
10/26/2010	Q3 2010	$0.32	$0.32	View	N/A
7/27/2010	Q2 2010	$0.18	$0.23	View	N/A
4/26/2010	Q1 2010	$0.14	$0.14	View	N/A
2/8/2010	Q4 2009	$0.23	$0.24	View	N/A
10/27/2009	Q3 2009	$0.32	$0.34	View	N/A
7/21/2009	Q2 2009	$0.29	$0.33	View	N/A
4/21/2009	Q1 2009	$0.39	$0.37	View	N/A
2/9/2009	Q4 2008	$0.44	$0.44	View	N/A
10/21/2008	Q3 2008	$0.43	$0.44	View	N/A
7/22/2008	Q2 2008	$0.39	$0.39	View	N/A
4/22/2008	Q1 2008	$0.43	$0.43	View	N/A
2/6/2008	Q4 2007	$0.34	$0.34	View	N/A

(Earnings results data provided by Zacks Investment Research)

Pharmaceutical Product Development (NASDAQ:PPDI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Pharmaceutical Product Development (NASDAQ PPDI) Insider Trading and Institutional Ownership History

Insider Trading History for Pharmaceutical Product Development (NASDAQ:PPDI)

Pharmaceutical Product Development (NASDAQ PPDI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

Pharmaceutical Product Development (NASDAQ PPDI) News Headlines

Source:

Date	Headline
	Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio www.bizjournals.com - April 6 at 3:28 PM
	This Morning's Technical Outlook on Generic Drugs Stocks -- Ironwood Pharma, Pacira Pharma, pSivida, and Tetraphase Pharma www.bizjournals.com - March 21 at 9:30 AM
	Isodiol International Inc. Signs Partnership Agreement With Kawacatoose First Nation globenewswire.com - March 20 at 9:42 AM
	BRIEF-Dova Pharmaceuticals Signs Distribution Agreement With Fosun Pharma For Mainland China And Hong Kong www.reuters.com - March 19 at 9:34 AM
	BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development www.streetinsider.com - March 15 at 3:30 PM
	Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging finance.yahoo.com - March 15 at 3:30 PM
	Avillion Signs Co-Development Agreement with Pearl Therapeutics Inc. (part of AstraZeneca) to Conduct Clinical Development of PT027 in Asthma www.bizjournals.com - March 13 at 3:36 PM
	Letter to Kasten Inc. Shareholders from President Steven J. Keough finance.yahoo.com - March 13 at 3:36 PM
	V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of Transformative Prodrug Technology Platform www.bizjournals.com - March 6 at 8:59 AM
	BRIEF-Vertex Pharma Says Established Wholesale Acquisition Cost Of $292,000 For SYMDEKO In U.S. On Annual Basis www.reuters.com - February 12 at 5:37 PM
	Pii and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017 www.bizjournals.com - February 9 at 6:34 PM
	TraceLink Dismisses Litigation Claims Against Healthcare Distribution Alliance (HDA) www.bizjournals.com - February 6 at 5:23 PM
	Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls www.thestreet.com - February 2 at 5:42 PM
	Archer Daniels & Vland Tie Up for Better Animal Feed Products finance.yahoo.com - January 19 at 11:35 AM
	Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI) www.bizjournals.com - January 17 at 10:03 AM
	Colorcon, Inc. Transforms the Sugar Coating Process with a New Opadry System www.businesswire.com - January 17 at 10:03 AM
	Leading Pharma, LLC Receives $40 Million in Growth Capital www.prnewswire.com - January 5 at 4:28 PM
	Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™ globenewswire.com - December 8 at 4:40 PM
	Global Pharmaceutical Drug Development Services Procurement Market Report 2017 - Top Suppliers are IQVIA, LabCorp, PAREXEL, ICON & INC Research finance.yahoo.com - December 8 at 4:40 PM
	Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Megestrol Acetate Oral Suspension (Megace® ES) www.prnewswire.com - December 4 at 4:44 PM
	RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development www.prnewswire.com - November 16 at 5:46 PM
	Velesco Pharma Awarded Subcontract to Develop and Manufacture Clinical Supplies for a New Treatment for Beta-Thalassemia www.businesswire.com - November 8 at 3:51 PM
	Versant, NEA Back Oyster Point Pharma www.businesswire.com - November 7 at 8:57 AM
	Isodiol International Inc. Announces Launch of Market’s First Hops-Derived CBD Products globenewswire.com - October 24 at 8:42 AM
	Innovation Pharmaceuticals Provides Development Update On Brilacidin For Inflammatory Bowel Disease www.thestreet.com - October 24 at 8:41 AM
	Isodiol International Inc. Provides Investor Update globenewswire.com - October 19 at 7:43 AM
	Isodiol International Inc. To Implement Blockchain Technology For Payment Processing www.thestreet.com - October 17 at 6:24 AM
	Medibio Limited: Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc. www.finanznachrichten.de - October 8 at 7:58 PM
	Sales of Legal Cannabis Products are Expected to Grow www.prnewswire.com - October 2 at 10:21 AM
	CanniMed Therapeutics Inc. and Avaria Health & Beauty Corp. to Partner on Research and Development of Cannabis-Based Topicals with Signing of LOI www.businesswire.com - October 2 at 10:21 AM
	Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum www.marketwatch.com - October 1 at 6:23 PM
	Breckenridge Pharmaceutical, Inc. and Impopharma, Inc. enter into licensing agreement www.bizjournals.com - September 30 at 5:58 PM
	Acquisition Of Zevacor Pharma Complete, Rebranding As SOFIE www.prnewswire.com - September 27 at 9:24 PM
	Microbial Identification Market by Product & Service, Method, Application, End User - Global Forecast to 2022 www.bizjournals.com - September 26 at 7:12 PM
	QuVa Pharma Announces FDA 503B Registration of its New Jersey Facility finance.yahoo.com - September 26 at 7:12 PM
	Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc. www.thestreet.com - September 20 at 7:55 AM
	Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices ... www.businesswire.com - September 20 at 7:55 AM
	Q BioMed Announces Development Partnership With Sphaera Pharma finance.yahoo.com - September 20 at 7:55 AM
	Charleston Laboratories, Inc. Reacquires Rights to Novel Investigational Treatment CL-108, for Acute Pain and Opioid-Induced Nausea and Vomiting www.bizjournals.com - August 31 at 8:53 AM
	Featured Company News - Jazz Pharma to Partner with ImmunoGen for the Development and Commercialization of Antibody-Drug Conjugate Products www.nasdaq.com - August 31 at 8:53 AM
	Athenex Pharmaceutical Division and SunGen Pharma Announce Terbutaline Sulfate Injection Product Launch globenewswire.com - August 31 at 8:53 AM
	Technical Snapshots for These Generic Drugs Stocks -- Allergan, Catalent, Tetraphase Pharma, and pSivida www.prnewswire.com - August 30 at 8:08 AM
	Global Medicated Skin Care Products Industry www.bizjournals.com - August 22 at 3:15 PM
	Recro Pharma Appoints Jyrki Mattila as Executive Vice President of Business Development www.nasdaq.com - August 22 at 1:35 AM
	Pharmaceutical Robots Market Analysis By Product, By Application, By End Use And Segment Forecasts, 2014 - 2025 www.prnewswire.com - August 22 at 1:35 AM
	Isodiol International Inc. July 2017 Corporate Update www.bizjournals.com - August 4 at 7:06 AM
	Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma www.prnewswire.com - June 12 at 8:02 AM
	Recro Pharma Appoints Ryan D. Lake as Senior Vice President of Finance and Chief Accounting Officer globenewswire.com - June 6 at 8:08 AM
	Acurian Announces Hiring of Tom Privette to Lead Global Business Development www.businesswire.com - May 25 at 12:39 AM
	INC Research to merge with inVentiv in latest contract medical research deal www.nasdaq.com - May 12 at 8:15 AM

Pharmaceutical Product Development (NASDAQ:PPDI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Pharmaceutical Product Development (NASDAQ:PPDI) Income Statement, Balance Sheet and Cash Flow Statement

Pharmaceutical Product Development (NASDAQ PPDI) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff